CoChat
Sign Up
Cited by 38Cancer survivorship and careAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesCancer-related cognitive impairment studies

Brief metacognitive therapy for emotional distress in adult cancer survivors.

Open access
Fisher, Peter L., Byrne, Angela, Fairburn, Louise, Ullmer, Helen, Abbey, Gareth, Salmon, Peter·2019·Frontiers in Psychology
DOI 10.3389/fpsyg.2019.00162PMC PMC6365419
Open this paper in CoChat — free accountOpen PDF

Abstract

Background: Adult cancer survivors often experience substantial psychological morbidity following the completion of acute cancer treatment. Unfortunately, current psychological interventions are of limited efficacy. This study explored if metacognitive therapy (MCT); a brief transdiagnostic psychological intervention was potentially efficacious and could be delivered effectively to adult cancer survivors with psychological morbidity. Method: An open trial with 3- and 6-months follow-up evaluated the treatment effects of MCT in 27 consecutively referred individuals to a clinical psychology health service specialising in psycho-oncology. Each participant received a maximum of six 1-hour sessions of MCT. Levels of anxiety, depression, fear of cancer recurrence, post-traumatic stress symptoms, health related quality of life, and metacognitive beliefs and processes were assessed using self-report questionnaires. Results: MCT was associated with statistically significant reductions across all outcome measures which were maintained through to 6 months follow-up. In the ITT sample on the primary treatment outcome measure, the Hospital Anxiety and Depression Scale-Total, 59% of participants met recovery criteria at post treatment and 52% at 6 months follow-up, respectively No participants significantly deteriorated. In the completer sample (N=20), 80% recovered at post-treatment and 70% at 6 months follow-up. MCT was acceptable to patients with approximately 75% of patients completing all treatment sessions. Conclusion: MCT, a brief transdiagnostic psychological intervention can be delivered effectively to a heterogenous group of cancer survivors with promising treatment effects. Examining the efficacy of brief MCT against the current gold standard psychological intervention would be a valuable advance towards improving the quality of life of cancer survivors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyg.2019.00162

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MCT is a feasible treatment with promising effects for mental disorders among somatically ill patients.

    “Findings show that MCT is a feasible treatment with promising effects in that patient group as well (26, 27).”

    From Metacognitive Short-Term Intervention in Patients With Mental Disorders Following Cardiovascular Events (2022) · cites this paper as [27]

    The Abstract and Discussion report that brief MCT was acceptable to adult cancer survivors and had promising effects on psychological morbidity. The study was an open trial in cancer survivors with emotional distress; it does not establish feasibility or effects across somatically ill patients generally or for diagnosed mental disorders. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

  • This is consistent with studies showing the effectiveness of MCT for patients with somatic diseases that caused or worsened psychiatric disorders.

    “This is consistent with studies showing the effectiveness of MCT for patients with somatic diseases that caused or worsened psychiatric disorders (26–28).”

    From Metacognitive Short-Term Intervention in Patients With Mental Disorders Following Cardiovascular Events (2022) · cites this paper as [27]

    The Discussion reports significant reductions in anxiety, depression and post-traumatic stress symptoms after brief MCT in adult cancer survivors, sustained to six months. The study concerns cancer survivors’ emotional distress, not somatic diseases generally; it also did not establish that cancer caused or worsened psychiatric disorders. The Discussion notes that changes in psychiatric diagnosis were not assessed. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

  • Preliminary studies of metacognitive therapy for treating anxiety and depression within physical illnesses show promising evidence.

    “Preliminary studies of metacognitive therapy for treating anxiety and depression within physical illnesses show promising evidence [67–69].”

    From Metacognitive beliefs and their relationship with anxiety and depression in physical illnesses: A systematic review (2020) · cites this paper as [68]

  • Initial studies suggest that metacognitive therapy is an acceptable and feasible intervention that was associated with positive outcomes.

    “These initial studies suggest that MCT is an acceptable and feasible intervention that was associated with positive outcomes.”

    From Metacognitive beliefs and their relationship with anxiety and depression in physical illnesses: A systematic review (2020) · cites this paper as [68]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 50 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Wells A. (2009). Metacognitive for Anxiety and Depression. New York, NY: Guildford Press.

Cited by

Sorted by citations

Related

Authors
Fisher, P. L., Byrne, A., Fairburn, L., Ullmer, H., Abbey, G., & Salmon, P.
Affiliations
University of Liverpool (GB)
Corresponding author
Fisher, Peter L.
ORCID
Venue
Frontiers in Psychology
Publisher
Frontiers Media SA
Published
2019-01-31
Volume
10
Pages
162-162
ISSN
1664-1078 (ISSN-L)
DOI
10.3389/fpsyg.2019.00162
PMC
PMC6365419
OpenAlex
W2912454299
Cited by
38
References
50
Citations by year
2026: 3 · 2024: 7 · 2023: 4 · 2022: 12 · 2021: 4 · 2020: 6 · 2019: 2
FWCI
2.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Frontiers in Psychology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Solent University Research Portal (Solent University) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Liverpool
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
Keywords
metacognitive therapy, cancer survivors, psychological distress, anxiety, depression, fear of cancer recurrence, posttraumatic stress symptoms, health-related quality of life, metacognitive beliefs, transdiagnostic treatment, psycho-oncology, brief psychological intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review